Department of Surgery, Skane University Hospital, Lund University, S-221 85 Lund, Sweden.
Langenbecks Arch Surg. 2012 Oct;397(7):1133-7. doi: 10.1007/s00423-012-0981-1. Epub 2012 Sep 14.
Postoperative hypocalcaemia has been reported to be more common after total thyroidectomy (TT) for Graves' disease than after TT for benign atoxic multinodular goitre (MNG). The reasons for this potential association are not clear. In the present study, the frequency and risk factors of hypocalcaemia after TT for Graves' vs MNG were compared.
Between January 1999 and October 2009, patients with first-time surgery for Graves' disease or MNG treated with a TT were included in the study. Postoperative hypocalcaemia was defined by symptoms, calcium levels and treatment with calcium and/or vitamin D analogues during postoperative hospital stay, at discharge, and at the 6-week and 6-month follow-ups. Outcomes were compared with Mann-Whitney, chi(2) and Fishers' exact test where appropriate and by multivariable logistic regression analysis.
There were 128 patients with Graves' disease and 81 patients with MNG. Patients with Graves' disease were younger than patients with MNG (median age, 35 vs 51 years, p < 0.001). Symptoms of hypocalcaemia were more common in patients with Graves' disease (p < 0.001; OR, 95 % CI 3.26, 1.48-7.14), but the frequency of biochemical hypocalcaemia, postoperative levels of parathyroid hormone (PTH) and treatment with calcium and vitamin D did not differ between groups of patients.
Apart from more frequent symptoms of hypocalcaemia in patients with Graves' disease, there was no difference in the overall frequency of biochemical hypocalcaemia, low levels of PTH and/or treatment with calcium and vitamin D.
与毒性多结节性甲状腺肿(MNG)相比,Graves 病行甲状腺全切除术(TT)后,低钙血症更为常见。这种潜在关联的原因尚不清楚。本研究比较了 Graves 病与 MNG 行 TT 后低钙血症的发生率和危险因素。
1999 年 1 月至 2009 年 10 月,Graves 病或 MNG 患者初次接受 TT 手术,纳入本研究。术后低钙血症通过症状、血钙水平以及术后住院期间、出院时和 6 周、6 个月随访期间使用钙和/或维生素 D 类似物进行治疗来定义。采用 Mann-Whitney、卡方和 Fisher 确切检验(如适用)以及多变量逻辑回归分析比较结局。
128 例 Graves 病患者和 81 例 MNG 患者纳入本研究。Graves 病患者比 MNG 患者年轻(中位数年龄 35 岁 vs 51 岁,p<0.001)。Graves 病患者更常出现低钙血症症状(p<0.001;比值比,95%置信区间 3.26,1.48-7.14),但两组患者的生化低钙血症发生率、术后甲状旁腺激素(PTH)水平以及钙和维生素 D 的治疗情况无差异。
除 Graves 病患者更常出现低钙血症症状外,生化低钙血症、低 PTH 水平和/或钙和维生素 D 治疗的总体发生率并无差异。